Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn the effectiveness of sorafenib combined
with gemcitabine plus cisplatin in the treatment of patients with locally advanced or
metastatic collecting duct carcinoma(CDC) of the kidney. The safety of each treatment will
also be studied.